Literature DB >> 17038651

Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases.

Rodolphe Fischmeister1, Liliana R V Castro, Aniella Abi-Gerges, Francesca Rochais, Jonas Jurevicius, Jérôme Leroy, Grégoire Vandecasteele.   

Abstract

A current challenge in cellular signaling is to decipher the complex intracellular spatiotemporal organization that any given cell type has developed to discriminate among different external stimuli acting via a common signaling pathway. This obviously applies to cAMP and cGMP signaling in the heart, where these cyclic nucleotides determine the regulation of cardiac function by many hormones and neuromediators. Recent studies have identified cyclic nucleotide phosphodiesterases as key actors in limiting the spread of cAMP and cGMP, and in shaping and organizing intracellular signaling microdomains. With this new role, phosphodiesterases have been promoted from the rank of a housekeeping attendant to that of an executive officer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17038651     DOI: 10.1161/01.RES.0000246118.98832.04

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  153 in total

Review 1.  A-kinase anchoring proteins that regulate cardiac remodeling.

Authors:  Graeme K Carnegie; Brian T Burmeister
Journal:  J Cardiovasc Pharmacol       Date:  2011-11       Impact factor: 3.105

2.  Study of the regulation of the inotropic response to 5-HT4 receptor activation via phosphodiesterases and its cross-talk with C-type natriuretic peptide in porcine left atrium.

Authors:  S Weninger; J H De Maeyer; R A Lefebvre
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-03-17       Impact factor: 3.000

Review 3.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

4.  The identification of novel cyclic AMP-dependent protein kinase anchoring proteins using bioinformatic filters and peptide arrays.

Authors:  William A McLaughlin; Tingjun Hou; Susan S Taylor; Wei Wang
Journal:  Protein Eng Des Sel       Date:  2010-11-29       Impact factor: 1.650

5.  The role of cGMP-dependent protein kinase in controlling cardiomyocyte cGMP.

Authors:  Sharron H Francis
Journal:  Circ Res       Date:  2010-11-12       Impact factor: 17.367

6.  Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury.

Authors:  Youn Wook Chung; Claudia Lagranha; Yong Chen; Junhui Sun; Guang Tong; Steven C Hockman; Faiyaz Ahmad; Shervin G Esfahani; Dahae H Bae; Nazari Polidovitch; Jian Wu; Dong Keun Rhee; Beom Seob Lee; Marjan Gucek; Mathew P Daniels; Christine A Brantner; Peter H Backx; Elizabeth Murphy; Vincent C Manganiello
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-15       Impact factor: 11.205

7.  Heterogeneous nuclear ribonucleoprotein A1 is a novel cellular target of atrial natriuretic peptide signaling in renal epithelial cells.

Authors:  Bahar Hesabi; Robert S Danziger; Kumar U Kotlo
Journal:  Cell Signal       Date:  2012-01-17       Impact factor: 4.315

8.  Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.

Authors:  Claire Y Zhao; Joseph L Greenstein; Raimond L Winslow
Journal:  J Mol Cell Cardiol       Date:  2015-09-23       Impact factor: 5.000

Review 9.  Membrane rafts and caveolae in cardiovascular signaling.

Authors:  Paul A Insel; Hemal H Patel
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

10.  Elevated cyclic AMP and PDE4 inhibition induce chemokine expression in human monocyte-derived macrophages.

Authors:  Angie L Hertz; Andrew T Bender; Kimberly C Smith; Mark Gilchrist; Paul S Amieux; Alan Aderem; Joseph A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.